Stocktoria
Ocugen, Inc. OCGN
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2014-12-03
Ocugen, Inc. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Johnson-Greene Treerita Essalima | Chief Financial Officer | 2026-06-15 | Buy | 21,000 | $1.23 |
| Zhang Junge | director | 2026-04-01 | Option exercise | 15,000 | $0.51 |
| Zhang Junge | director | 2026-04-01 | Option exercise | 112,205 | $0.46 |
| Zhang Junge | director | 2026-04-01 | Option exercise | 66,929 | $1.42 |
| Musunuri Shankar | Chief Executive Officer | 2026-01-02 | Grant | 3,123,201 | — |
| Ramachandran Ramesh | Chief Accounting Officer | 2026-01-02 | Grant | 207,300 | — |
Source: SEC EDGAR filings · CIK 0001372299 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.